X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (112) 112
female (92) 92
breast cancer (68) 68
middle aged (66) 66
index medicus (63) 63
oncology (59) 59
adult (48) 48
breast neoplasms - pathology (46) 46
aged (45) 45
male (36) 36
medicine & public health (34) 34
animals (30) 30
cancer (29) 29
breast neoplasms - drug therapy (28) 28
surgery (28) 28
prognosis (24) 24
breast neoplasms - metabolism (21) 21
expression (21) 21
surgical oncology (20) 20
care and treatment (18) 18
mice (18) 18
aged, 80 and over (17) 17
hematology, oncology and palliative medicine (17) 17
analysis (16) 16
chemotherapy (16) 16
breast neoplasms - genetics (15) 15
cancer research (15) 15
metastasis (15) 15
cell line, tumor (14) 14
health aspects (14) 14
medicine, research & experimental (14) 14
research (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
breast neoplasms - surgery (13) 13
therapy (13) 13
immunohistochemistry (12) 12
tumors (12) 12
apoptosis (11) 11
lymphatic metastasis (11) 11
receptors, estrogen - metabolism (11) 11
tamoxifen (11) 11
abdominal surgery (10) 10
carcinoma (10) 10
cells (10) 10
dose-response relationship, drug (10) 10
estrogen (10) 10
neoplasm staging (10) 10
pharmacology & pharmacy (10) 10
receptor, erbb-2 - metabolism (10) 10
women (10) 10
breast neoplasms - mortality (9) 9
cardiac surgery (9) 9
genetic aspects (9) 9
growth (9) 9
japan (9) 9
medical colleges (9) 9
mice, nude (9) 9
rats (9) 9
retrospective studies (9) 9
reverse transcriptase polymerase chain reaction (9) 9
survival (9) 9
thoracic surgery (9) 9
vascular surgery (9) 9
antineoplastic agents - therapeutic use (8) 8
breast neoplasms - diagnostic imaging (8) 8
cancer patients (8) 8
gene (8) 8
gene expression (8) 8
obstetrics & gynecology (8) 8
risk (8) 8
treatment outcome (8) 8
tumor cells, cultured (8) 8
biomarkers, tumor - metabolism (7) 7
breast neoplasms - therapy (7) 7
calibration (7) 7
cell proliferation (7) 7
trial (7) 7
adjuvant treatment (6) 6
antineoplastic agents - pharmacology (6) 6
blotting, western (6) 6
breast-cancer (6) 6
combined modality therapy (6) 6
docetaxel (6) 6
doxorubicin - administration & dosage (6) 6
epidermal growth factor (6) 6
fluorouracil - administration & dosage (6) 6
instruments & instrumentation (6) 6
medicine (6) 6
neoplasm invasiveness (6) 6
oncology, experimental (6) 6
proteins (6) 6
research article (6) 6
rna, messenger - genetics (6) 6
stomach neoplasms - pathology (6) 6
survival rate (6) 6
tomography, x-ray computed (6) 6
trastuzumab (6) 6
activation (5) 5
adjuvant therapy (5) 5
cancer therapies (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Gene Therapy, ISSN 0929-1903, 01/2009, Volume 16, Issue 1, pp. 65 - 72
The overexpression of reduced expression in immortalized cells (REIC)/Dickkopf-3 (Dkk-3), a tumor suppressor gene, induced apoptosis in human prostatic and... 
P-glycoprotein | Breast cancer | REIC/Dkk-3 | Apoptosis | MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | METASTASIS | breast cancer | apoptosis | DICKKOPF-3 | INHIBITS TUMOR-GROWTH | IN-VITRO | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | PROSTATE-CANCER | GENETICS & HEREDITY | GENE-THERAPY | SUPPRESSES | PROTEINS | EXPRESSION | Doxorubicin - therapeutic use | Genetic Therapy | Neoplasm Transplantation | Adenoviridae | Antibiotics, Antineoplastic - pharmacology | Apoptosis - drug effects | Drug Resistance, Multiple - drug effects | Humans | Apoptosis - genetics | Intercellular Signaling Peptides and Proteins - biosynthesis | Breast Neoplasms - metabolism | Breast Neoplasms - therapy | MAP Kinase Kinase 4 - metabolism | Female | Drug Resistance, Multiple - genetics | Intercellular Signaling Peptides and Proteins - genetics | ATP-Binding Cassette, Sub-Family B, Member 1 - biosynthesis | Down-Regulation - drug effects | Enzyme Activation - drug effects | Down-Regulation - genetics | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Antibiotics, Antineoplastic - therapeutic use | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Mice, Nude | MAP Kinase Kinase 4 - genetics | Mice | HeLa Cells | Enzyme Activation - genetics | Doxorubicin - pharmacology | Drug Resistance, Neoplasm - drug effects | Genetic aspects | Research | Gene expression | Gene therapy | Health aspects | Risk factors
Journal Article
by Blackhall, F and Peters, S and Kerr, K. M and O'Byrne, K and Hager, H and Sejda, A and Soltermann, A and Dooms, C and Felip, E and Marchetti, A and Speel, E.-J. M and Price, N and Savic, S and de Jong, J and Martorell, M and Thunnissen, E and Bubendorf, L and Dafni, O and Rosell, R and Stahel, R. A and Nygaard, A. D and Spindler, K and Andersen, R and Pallisgaard, N and Jakobsen, A and O'Leary, K and Shia, A and Haley, V and Cavicchioli, F and Comino, A and Vanella, P and Wischnewsky, M and Crook, T and Nigro, C. L and Schmid, P and Janne, P. A and Shepherd, F. A and Domerg, C and Le Teuff, G and Kratzke, R and Hainaut, P and Pignon, J and Soria, J and Tsao, M and Dawson, S and Tsui, D and Murtaza, M and Biggs, H and Chin, S and Gale, D and Forshew, T and Wallis, M and Rosenfeld, N and Caldas, C and Iwamoto, T and Pusztai, L and Matsuoka, J and Callari, M and Kelly, C. M and Qi, Y and Motoki, T and Taira, N and Santarpia, L and Doihara, H and Gianni, L and Bianchini, G and Martinelli, E and Troiani, T and Morgillo, F and D'Aiuto, E and Ciuffrida, L and Costantini, S and Vecchione, L and De Vriendt, V and Tejpar, S and Ciardiello, F and Terme, M and Pernot, S and Marcheteau, E and Colussi, O and Sandoval, F and Benhamouda, N and Tartour, E and Taieb, J and Chasalow, S. D and Wolchok, J. D and Reck, M and Maier, S and Shahabi, V and Cuzick, J and Sestak, I and Ferree, S and Cowens, J. W and Dowsett, M and Kloecker, G and Taylor, C and Vinayek, N and Taylor, D and Pircher, A and Untergasser, G and ...
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix73 - ix94
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2009, Volume 106, Issue 9, pp. 3408 - 3413
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 11/2012, Volume 136, Issue 2, pp. 331 - 345
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 8/2019, Volume 176, Issue 3, pp. 631 - 635
While some studies show improved outcomes in clinical trial participants as compared to non-participants, existence of such a trial effect has not been proved... 
Medicine & Public Health | Prospective cohort study | Trial effect | Oncology | SELECT BC | Overall survival | Randomized control trial | CELL LUNG-CANCER | ONCOLOGY | CLINICAL-TRIALS | OUTCOMES | Medical research | Care and treatment | Chemotherapy | Prognosis | Patient outcomes | Clinical trials | Medicine, Experimental | Metastasis | Research | Comparative analysis | Cancer
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 02/2007, Volume 120, Issue 3, pp. 566 - 573
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 02/2014, Volume 13, Issue 2, pp. 329 - 340
Activation of anaplastic lymphoma receptor tyrosine kinase (ALK) is involved in the pathogenesis of several carcinomas, including non-small cell lung cancer... 
GEFITINIB | ALK INHIBITORS | FUSION | GENE | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | INTRATUMOR HETEROGENEITY | ACQUIRED-RESISTANCE | CRIZOTINIB | ACTIVATING MUTATIONS | CHRONIC MYELOID-LEUKEMIA | Lung Neoplasms - drug therapy | Paclitaxel - pharmacology | Guanine - analogs & derivatives | Humans | Lung Neoplasms - metabolism | Immunoblotting | Sulfones - pharmacology | Protein Kinase Inhibitors - chemistry | Sulfones - chemistry | Guanine - pharmacology | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Triazines - chemistry | Antineoplastic Agents - pharmacology | Molecular Structure | Lung Neoplasms - genetics | Protein Kinase Inhibitors - pharmacokinetics | Cell Survival - drug effects | Triazines - pharmacology | Carcinoma, Non-Small-Cell Lung - genetics | Mice, Inbred C57BL | Carcinoma, Non-Small-Cell Lung - metabolism | Mice, Transgenic | Sulfones - pharmacokinetics | Mice, SCID | Receptor Protein-Tyrosine Kinases - metabolism | Pemetrexed | Drug Synergism | Xenograft Model Antitumor Assays | Animals | Receptor Protein-Tyrosine Kinases - genetics | Tumor Burden - drug effects | Glutamates - pharmacology | Survival Analysis | Mice, Inbred NOD | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | 3T3 Cells | Triazines - pharmacokinetics | Index Medicus
Journal Article
Molecular and Cellular Biochemistry, ISSN 0300-8177, 2009, Volume 331, Issue 1-2, pp. 239 - 245
Journal Article
Breast Cancer Research, ISSN 1465-5411, 07/2016, Volume 18, Issue 1, p. 73
Journal Article
Journal Article